SUMMARY The current methods of diagnosis for non-specific genital infection (NSGI) in clinics in England and Wales are described. In most clinics (92%) microscopical findings were used by consultants to establish the diagnosis of non-specific urethritis (NSU) in male patients. However, the microscopical criteria that they used in reaching a diagnosis varied between clinics. The most commonly applied criterion was that of less than five leucocytes per high power field. NSGI in female patients and non-specific proctitis in passive homosexuals were recognised as distinct clinical entitities by only some physicians; the former was acknowledged by consultants working in 60% of clinics and the latter in 57 %. Among those who recognised these conditions the diagnostic criteria varied. The establishment of acceptable and uniform criteria for diagnosis are discussed.
Introduction Results
Consultants were first asked to notify non-specific genital infection (NSGI) as a separate item in the quarterly returns in 1971. Previously, since 1951, only cases in men were recorded in the category of 'nongonococcal urethritis'. Since that time the number of cases reported in men has risen by over 500 %. Nongonococcal or non-specific urethritis (NSU) is now the most commonly notified sexually transmitted disease (STD) in England and Wales.
Previous papers Adler, 1978a, b; Belsey and Adler, 1978) have described the methods used during an inquiry into the facilities and patterns of care for patients with gonorrhoea and herpes genitalis in STD clinics in England and Wales. This paper is concerned with the current management of NSGI by consultants working in 173 clinics for female patients and 171 clinics for male patients. The first part of the paper describes the diagnosis of NSGI and the second the treatment and reporting criteria used in the clinics.
NSU in male patients
The consultants in charge of clinics were asked to indicate the criteria that they used to make a diagnosis of NSU on microscopical examination of urethral secretions from male patients. Table 1 shows the range of numbers of leucocytes per high power field (HPF) that they used to make a diagnosis, and these varied between clinics. The criteria are not mutually exclusive. The most commonly applied criterion was that of less than five leucocytes per HPF and was used in 113 (66%) clinics. The next cervicitis and mucopurulent or purulent cervical discharge were the findings most commonly mentioned. Since there is so much variation in the definition and observation of cervicitis and discharge no attempt was made to define this entity in the study or to ask the physicians to do so. In 17 (16 %) clinics positive culture results were mentioned, the most commonly cited organisms being Chlamydia or Ureaplasma urealyticum.
All the consultants who indicated that they recognised the condition of NSGI in women as a distinct clinical entity gave treatment to the patient.
Non-specific proctitis in passive homosexual patients Non-specific proctitis was recognised as a distinct clinical entity by consultants working in 98 (570%) clinics even if the patient was not a sexual contact of a man with NSU. They were asked to stipulate the criteria that they used to reach this diagnosis (Table 3 ). In most clinics in which the condition 
Female contacts
In almost all the clinics (96%) at which female patients were seen attempts were made to see all or selected female sexual contacts of male patients with NSU. Physicians working in 76 clinics attempted to see all sexual contacts, but the most frequent practice (in 90 clinics) was to see only selected ones. The two commonest reasons for selection were: (1) that the sexual contact was the patient's regular partner; and (2) that the original male patient had had a recurrence of NSU after an adequate course of treatment (Table 4) . In a few clinics sexual contacts were seen if the contact wished to come and attendance at the clinic would not disrupt the relationship or if the patient indicated that the sexual contact had genital symptoms In most clinics (66%) the criteria of less than five leucocytes per HPF was used whereas in 26% of clinics five or more leucocytes per HPF were required, and in a further 8 % no attempt was made at quantification. Some venereologists will submit that a leucocyte count of less than five per HPF is too low, whereas others will argue that a patient with urethritis due to Chlamydia can have both a minimal count and a urethral discharge which would be left undiagnosed and untreated if higher counts were required. While there is little to be gained from argument about whether the use of less than five leucocytes per HPF is too low it must be realised that one physician's definition of NSU is not necessarily another's. It is extremely unsatisfactory that when NSU is discussed, described, diagnosed, and notified no accepted criteria are in existence. The ideal solution would be for all physicians to agree on a standard criterion and universally applied 'cut off' point for establishing the diagnosis if no organism is isolated. Such a step would remove some of the imprecision surrounding the diagnosis and definition of this disease. It must be realised that if those working in the field of genitourinary medicine decided to recommend that the diagnosis of NSU be made on the basis of less than five leucocytes per HPF the number of reported cases will appear to increase, since physicians using the more stringent criteria will start to diagnose and report patients as having NSU who would have previously been considered normal. If a standard criterion is not acceptable to venereologists it might be possible to persuade them to indicate their own individual criterion currently in use to establish a diagnosis.
Physicians working in 17 clinics made a diagnosis of NSU on the basis of the two-glass urine test in the absence of symptoms. The two-glass urine test is subjective, unreliable, and no substitute for microscopy. The difficulties in establishing universally acceptable microscopical criteria should not deter doctors from using this method as the basis for diagnosis as opposed to relying on the two-glass urine test alone.
Despite Burns et al (1975) . Atia and Thin (1975) also looked at the value of cytology in diagnosing genital infection and showed that women with gonorrhoea, trichomoniasis, and-to a lesser extent -candidosis exhibited inflammatory changes and that it was important to exclude these diseases before the patient was diagnosed as having NSGI. Earle (1977) (Oriel, 1976) . A further problem arises when a decision has to be made whether to treat all sexual contacts or only those with evidence of infection, such as cervicitis or mucopurulent or purulent cervical discharge. Csonka (1972) Fewer consultants recognised non-specific proctitis as a distinct clinical entity than NSGI in female patients. In both instances there is little agreement as to whether or not the condition exists and, if it does, as to the appropriate criteria for diagnosis. Fluker (1976) has summed this up: 'the criteria for diagnosis are as nebulous as those for non-specific genital infection in the female and largely depend on known contact with a case of non-specific urethritis in the absence of Neisseria gonorrhoeae in smears and cultures'. Once again, it is obvious that work is required to establish more accurate and acceptable criteria, and that at present it is preferable to accept that non-specific proctitis is not a distinct entity.
Conclusions
Non-specific genital infection is now the commonest diagnosis made in STD clinics in England and Wales yet the one with the least uniformity in the establishment of a diagnosis and the notification of cases. The absence of a causative organism which can be identified by routine laboratory methods in most cases makes it all the more important that a standard approach to diagnosis is developed. This may not be possible in women. Work with Chlamydia trachomatis has shown that a diagnosis of chlamydial cervical infection cannot be made by clinical examination, microscopy, and exclusion of Neisseria gonorrhoeae and Trichomonas vaginalis.
